Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 7336 AL 7350

Biochemical markers in Alzheimer's disease clinical trials

Zetterberg H, Mattsson N, Shaw LM, Blennow K.

Biomark Med. 2010 Feb;4(1):91-8. doi: 10.2217/bmm.09.80.

Cerebrospinal fluid proteins in the diagnosis of Alzheimer's disease

Papaliagkas VT, Tsolaki M, Anogianakis G.

Recent Pat CNS Drug Discov. 2010 Jun;5(2):172-8. doi: 10.2174/157488910791213194.

Integrating ADNI results into Alzheimer's disease drug development programs

Cummings JL.

Neurobiol Aging. 2010 Aug;31(8):1481-92. doi: 10.1016/j.neurobiolaging.2010.03.016. Epub 2010 May 5.

Geriatric medicine, Japanese Alzheimer's disease neuroimaging initiative and biomarker development

Arai H, Okamura N, Furukawa K, Kudo Y.

Tohoku J Exp Med. 2010 Jun;221(2):87-95. doi: 10.1620/tjem.221.87.

Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers

Serrano-Pozo A, Vega GL, Lütjohann D, Locascio JJ, Tennis MK, Deng A, Atri A, Hyman BT, Irizarry MC, Growdon JH.

Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):220-6. doi: 10.1097/WAD.0b013e3181d61fea.

Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment

Lorenzi M, Donohue M, Paternicò D, Scarpazza C, Ostrowitzki S, Blin O, Irving E, Frisoni GB; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2010 Aug;31(8):1443-51, 1451.e1. doi: 10.1016/j.neurobiolaging.2010.04.036. Epub 2010 Jun 11.

Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets?

Mielke MM, Lyketsos CG.

Neuromolecular Med. 2010 Dec;12(4):331-40. doi: 10.1007/s12017-010-8121-y. Epub 2010 Jun 23.

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, Herholz K, Bokde AL, Jessen F, Hoessler YC, Sanhai WR, Zetterberg H, Woodcock J, Blennow K.

Nat Rev Drug Discov. 2010 Jul;9(7):560-74. doi: 10.1038/nrd3115.

BACE: Therapeutic target and potential biomarker for Alzheimer's disease

Evin G, Barakat A, Masters CL.

Int J Biochem Cell Biol. 2010 Dec;42(12):1923-6. doi: 10.1016/j.biocel.2010.08.017. Epub 2010 Sep 15.

Biomarkers for the early stages of clinical development in Alzheimer's disease

Bordet R, Dartigues JF, Dubois B, Goehrs JM, Vernoux L, Semah F, Pasquier F, Bidaut-Mazel C; participatnts of Round Table n°3 if Giens XXV.

Therapie. 2010 Jul-Aug;65(4):285-90, 277-283. doi: 10.2515/therapie/2010040. Epub 2010 Sep 21.

[Surrogate marker for ABeta42]

Okochi M, Tagami S, Yanagida K, Takeda M.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2010 Aug;30(4):169-72.

Biomarkers for Alzheimer's disease therapeutic trials

Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, Weiner M, Winblad B, Coley N, Vellas B; Oxford Task Force Group.

Prog Neurobiol. 2011 Dec;95(4):579-93. doi: 10.1016/j.pneurobio.2010.11.005. Epub 2010 Dec 2.

Letter from the Editor: stratified medicine

Reichert JM.

MAbs. 2010 Mar-Apr;2(2):107. doi: 10.4161/mabs.2.2.11320.

A Novel Perspective on PCSK9 in Alzheimer's Disease: A Focus on Amyloid Beta

Zhang H, Xu Q, Zhao Y, He N, Ren Z, Xiang Q, Tang Z, Liu L.

Curr Med Chem. 2025;32(22):4516-4528. doi: 10.2174/0109298673269288231123095215.

The Therapeutic Potential of Melatonin in Alzheimer's Disease: A Comprehensive Review

Zhang J, Feng M, Kong L.

Curr Med Chem. 2025;32(25):5139-5154. doi: 10.2174/0109298673286807240326085736.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias